Alerts will be sent to your verified email
Verify Email
ZYDEN
|
Zyden Gentec
|
Hemo Organic
|
Kobo Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-24.76 % | -361.35 % | -1.77 % |
|
5yr average Equity Multiplier
|
2.0 | -1.56 | 4.06 |
|
5yr Average Asset Turnover Ratio
|
0.21 | 0.14 | 0.54 |
|
5yr Avg Net Profit Margin
|
-137.59 % | -763.22 % | -3.79 % |
|
Price to Book
|
n/a | 0.0 | 0.0 |
|
P/E
|
n/a | 34.9 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
785.76 Days | 100.48 Days | 0.0 |
|
Inventory Days
|
134.34 Days | 406.93 Days | 89.28 Days |
|
Days Receivable
|
803.05 Days | 196.55 Days | 0.0 |
|
Days Payable
|
421.99 Days | 2776.86 Days | 147.48 Days |
|
5yr Average Interest Coverage Ratio
|
-2.08 | -250.54 | 0.99 |
|
5yr Avg ROCE
|
-6.92 % | 37.52 % | 11.79 % |
|
5yr Avg Operating Profit Margin
|
-95.87 % | -745.72 % | 8.83 % |
|
5 yr average Debt to Equity
|
0.68 | -0.73 | 1.62 |
|
5yr CAGR Net Profit
|
-1.66 % | n/a | n/a |
|
5yr Average Return on Assets
|
-15.88 % | -33.34 % | -0.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 16.85 % | 44.95 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.28 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zyden Gentec
|
Hemo Organic
|
Kobo Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|